ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,090Medicare Part D Prescriptions Filled, Including Refills

Rank: 130 out of 551

$327K Total Retail Price of All Prescriptions

Rank: 187 out of 551

384 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
3% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 10,698 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$27 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 1,125 1,007 1 1
LOSARTAN POTASSIUM 551 502 2 6
GLIMEPIRIDE 527 459 3 16
LEVOTHYROXINE SODIUM 513 427 4 9
AMLODIPINE BESYLATE 373 351 5 4
METFORMIN HCL ER 360 328 6 67
RANITIDINE HCL 348 308 7 8
METFORMIN HCL 335 264 8 2
ATENOLOL 324 300 9 12
OMEPRAZOLE 293 258 10 7
TRIAMTERENE-HCTZ 274 222 11 151
FUROSEMIDE 263 246 12 13
METOPROLOL SUCCINATE 260 228 13 23
ATORVASTATIN CALCIUM 258 223 14 29
LOSARTAN-HYDROCHLOROTHIAZIDE 253 232 15 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 252 239 16 59
CHLORTHALIDONE 231 220 17 165
LISINOPRIL 228 201 18 14
METOPROLOL TARTRATE 218 198 19 17
SYNTHROID 206 192 20 11
TAMSULOSIN HCL 173 160 21 38
ISOSORBIDE MONONITRATE ER 163 152 22 21
GABAPENTIN 139 135 23 3
ASPIRIN EC 128 124 24 26
INDAPAMIDE 126 120 25 116
ENALAPRIL MALEATE 122 111 26 5
CARVEDILOL 119 101 27 22
WARFARIN SODIUM 115 104 28 46
QUINAPRIL HCL 109 91 29 104
HUMULIN 70-30 106 95 30 35
LANTUS 105 94 31 28
DIGOXIN 103 102 32 44
TRAMADOL HCL-ACETAMINOPHEN 101 83 33 18
INSULIN SYRINGE 89 62 34 41
COUMADIN 83 75 35 88
PRAVASTATIN SODIUM 80 61 36 24
PLAVIX 75 70 37 33
SPIRONOLACTONE 68 68 38 79
FENOFIBRATE 66 44 39 34
CLOTRIMAZOLE-BETAMETHASONE 65 46 40 49
FINASTERIDE 63 63 41 82
TRAMADOL HCL 61 56 42 32
NABUMETONE 59 49 43 37
HYDROCHLOROTHIAZIDE 58 55 44 15
ZOLPIDEM TARTRATE 55 46 45 27
CLOPIDOGREL 52 49 46 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 19, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.